Publications While At Healthpartners
Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC
American Journal of Clinical Oncology.
Variation in care improvement opportunities suggests need for tailored clinician-specific improvement interventions [abstract]
Journal of patient-centered research and reviews.
Map of science